This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.
An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).
A fact sheet which includes information about fentanyl for both people who use drugs and Healthcare providers.
Describes strategies to help reduce the potential for misuse or diversion of medication for SUD treatment.
Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.
This is an opinion piece that provides background, recommendations, and conclusions for the treatment of pregnant women with opioid use and opioid use disorder, to improve maternal and infant outcomes.
Email Updates